Security key
15102K100
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 39,061,170
- Total 13F value
- $1,929,577,850
- Share change
- +7,185,837
- Put/Call ratio
- 36%
- SEC-reported price per share
- $49.40
- Number of holders
- 175
- Value change
- +$426,402,254
- Number of buys
- 136
- Number of sells
- 47
- Shares outstanding
- 48,772,277
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
175
Top holders
10
CELC full security history
Ownership snapshot
Full 13F holder table
Celcuity Inc. SEC filings
Celcuity Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of CELC - Celcuity Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Soleus Capital Master Fun...
Disclosed value leader
Brian F. Sullivan
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: Soleus Capital Master Fund, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Soleus Capital Master Fund, L.P. leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Soleus Capital Master Fund, L.P.'s linked filing trail.
Comparable ownership
Top 5
Soleus Capital Master Fund, L.P.
9.9%
Brian F. Sullivan
9.1%
BlackRock, Inc.
5.9%
Lance G. Laing
3.6%
Commodore Capital LP
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Soleus Capital Master Fund, L.P. |
13D/G
|
9.9%
|
$42,748,911
3,872,184 shares
|
$0 | 31 Dec 2024 |
| Brian F. Sullivan |
13D/G
|
9.1%
|
$198,252,228
4,013,203 shares
|
$0 | 30 Sep 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.9%
from 13D/G
|
$27,643,617
2,070,683 shares
|
— | 30 Jun 2025 |
| Lance G. Laing |
13D/G
|
3.6%
|
$77,497,040
1,568,766 shares
|
$0 | 30 Sep 2025 |
| Commodore Capital LP |
13D/G
|
2.9%
|
$12,095,976
1,095,650 shares
|
$0 | 31 Dec 2024 |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
BVF PARTNERS L P/IL
|
1.6%
|
$32,525,997
658,421 shares
|
$0 | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
175
Shares
39,061,170
Rows available
175
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
96
Q3 2025 holders
175
Holder diff
79
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|